Heron Therapeutics Inc
NASDAQ:HRTX

Watchlist Manager
Heron Therapeutics Inc Logo
Heron Therapeutics Inc
NASDAQ:HRTX
Watchlist
Price: 1.37 USD Market Closed
Market Cap: 251.2m USD

Wall Street
Price Targets

HRTX Price Targets Summary
Heron Therapeutics Inc

Wall Street analysts forecast HRTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HRTX is 4.59 USD with a low forecast of 3.03 USD and a high forecast of 6.3 USD.

Lowest
Price Target
3.03 USD
121% Upside
Average
Price Target
4.59 USD
235% Upside
Highest
Price Target
6.3 USD
360% Upside
Heron Therapeutics Inc Competitors:
Price Targets
SCLP
Scancell Holdings PLC
219% Upside
145020
Hugel Inc
72% Upside
RCKT
Rocket Pharmaceuticals Inc
133% Upside
ADAG
Adagene Inc
433% Upside
1530
3SBio Inc
38% Upside
TECX
AVROBIO Inc
318% Upside
ABBV
Abbvie Inc
11% Upside
87S
Roivant Sciences Ltd
19% Upside

Revenue
Forecast

Revenue Estimate
Heron Therapeutics Inc

For the last 13 years the compound annual growth rate for Heron Therapeutics Inc's revenue is 52%. The projected CAGR for the next 3 years is 12%.

52%
Past Growth
12%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Heron Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Heron Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-58%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HRTX's stock price target?
Price Target
4.59 USD

According to Wall Street analysts, the average 1-year price target for HRTX is 4.59 USD with a low forecast of 3.03 USD and a high forecast of 6.3 USD.

What is Heron Therapeutics Inc's Revenue forecast?
Projected CAGR
12%

For the last 13 years the compound annual growth rate for Heron Therapeutics Inc's revenue is 52%. The projected CAGR for the next 3 years is 12%.

Back to Top